Premier Alternatives

EpiPaws

Fort Lauderdale, FL · Founded 2022 · Privately Held (backing)

Developer of epigenetic biomarkers intended to promote proactive pet healthcare. EpiPaws is based in Fort Lauderdale, FL and was founded in 2022. Its last reported valuation was $1.3 million in Dec 2024. It has raised $420,000.

Last reported valuation
$1.3M
Oct 2026
Priced at
—
Total raised
$420K
Last round
—

EpiPaws key facts

as of Oct 2026
  • Developer of epigenetic biomarkers intended to promote proactive pet healthcare.
  • EpiPaws is valued at approximately $1.3M as of Oct 2026 (last reported valuation).
  • It has raised $420K; the latest was Angel (individual) ($140K) in Aug 2025.
  • Notable investors include Plug and Play Tech Center, MedTech Innovator, BioTools Innovator, Fau Tech Runway, Kevin O'Leary — 7 tracked in total.
  • EpiPaws has filed 1 Form D with the SEC, most recently Aug 2025 ($145K sold to 5 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$1.3M

EpiPaws's last reported valuation, Dec 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Private Market View
More of EpiPaws with a free Private Market View account
  • ·Watch EpiPaws: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

EpiPaws funding rounds

No rounds on record

No funding rounds for EpiPaws are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

EpiPaws valuation

EpiPaws's last reported valuation was $1.3 million in Dec 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has EpiPaws raised?

EpiPaws has filed 1 Form D with the SEC, most recently in Aug 2025 ($145,000 sold to 5 investors).

EpiPaws investors

7 investors are on record for EpiPaws, including Plug and Play Tech Center, MedTech Innovator, BioTools Innovator and Fau Tech Runway.

About EpiPaws

Developer of epigenetic biomarkers intended to promote proactive pet healthcare. The company offers biomarker tests to improve pet healthcare and increase pet longevity through better biomarkers, optimizing diets, and the development of nutraceuticals that help keep pets happy and healthy, enabling pet owners to learn how to feed, exercise, and monitor the health of a dog or cat.

Sector
Consumer Products and Services (B2C)
HQ
Fort Lauderdale, FL, United States
Founded
2022
Employees
7
Ownership
Privately Held (backing)

Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.